<

 
Data updated 2025-05-01 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date08771043.0 (espacenet)  (Federated)  (European Patent Register), 20080613
Patent/reg. no. and dateDK/EP 2167038, 20180425
Publication date20100331
Priority no. and dateUS 943618 P, 20070613, US 24031, 20080128
EP pub. no. and date EP 2167038 20100331
Effective date
Applicant/ownerZymogenetics, Inc., 1201 Eastlake Avenue East
Seattle, WA 98102, US,
ARES TRADING S.A., Zone Industrielle de l'Ouriettaz
1170 Aubonne, CH
Applicant ref. no.P021321EPDK1
InventorPENA ROSSI, Claudia, 8, rue Emile Yung
CH-1205 Geneva, CH,
BUSBY, Sharon J., 4109 Meridian Avenue North
Seattle, Washington 98103, US,
GROSS, Jane A., 4258 NE 74th Street
Seattle, Washington 98115, US,
NESTOROV, Ivan, 26125 SE 39th Ct
Issaguah, Washington 98029, US,
MUNAFO, Alain, Rue des Pressoirs 6
CH-1180 Tartegnin, CH,
PAPASOULIOTIS, Orestis, 82 Route de Frontenex
CH-1208 Geneva, CH,
VISICH, Jennifer, 1 DNA Way
MS 70
San Francisco, CA 94080, US
RepresentativeCHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK
Opponent
IPC ClassA61K 38/00 (2006.01) , A61K 9/00 (2006.01) , A61K 9/06 (2006.01) 
TitleANVENDELSE AF TACI-IG FUSIONPROTEIN SOM ATACICEPT TIL FREMSTILLING AF ET MEDICAMENT TIL BEHANDLING AF LUPUS ERYTHEMATOSUS
Int. application no.US2008066945
Int. publication no.WO2008157369
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact